Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer
AbstractLung cancer is the leading cause of cancer deaths worldwide. It is an aggressive and devastating cancer because of metastasis triggered by enhanced migration and invasion, and resistance to cytotoxic chemotherapy. The epithelial to mesenchymal transition (EMT) is a fundamental developmental process that is reactivated in wound healing and a variety of diseases including cancer where it promotes migration/invasion and metastasis, resistance to treatment, and generation and maintenance of cancer stem cells. The induction of EMT is associated with reprogramming of the epigenome. This review focuses on major mechanisms of epigenetic regulation mainly in lung cancer with recent data on EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit ), the catalytic subunit of the PRC2 (Polycomb Group PcG), that behaves as an oncogene in lung cancer associated with gene repression, non-coding RNAs and the epitranscriptome. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Roche, J.; Gemmill, R.M.; Drabkin, H.A. Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer. Cancers 2017, 9, 72.
Roche J, Gemmill RM, Drabkin HA. Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer. Cancers. 2017; 9(7):72.Chicago/Turabian Style
Roche, Joëlle; Gemmill, Robert M.; Drabkin, Harry A. 2017. "Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer." Cancers 9, no. 7: 72.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.